Literature DB >> 23334275

Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center.

C Solano, B Muñoz-Cobo, E Giménez, M J Remigia, P Amat, M A Clari, D Bravo, I Benet, J Montoro, D Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23334275     DOI： 10.1038/bmt.2012.286

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.

Authors:  C Solano; E Giménez; J L Piñana; V Vinuesa; S Poujois; S Zaragoza; M Calabuig; D Navarro
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Authors:  E Albert; C Solano; E Giménez; D Focosi; A Pérez; L Macera; J L Piñana; J C H Boluda; F Maggi; D Navarro
Journal:  Bone Marrow Transplant       Date:  2017-10-30       Impact factor: 5.483

3.  Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?

Authors:  Estela Giménez; Beatriz Muñoz-Cobo; Carlos Solano; Paula Amat; David Navarro
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

4.  Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Alberto Talaya; Estela Giménez; Víctor Vinuesa; Ariadna Pérez; Paula Amat; José Luis Piñana; Eliseo Albert; Juan Carlos Hernández-Boluda; Carlos Solano; David Navarro
Journal:  Med Microbiol Immunol       Date:  2019-03-25       Impact factor: 3.402

5.  Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft-versus-host disease prophylaxis.

Authors:  Rafael Hernani; José Luis Piñana; Ariadna Pérez; Abdiel Quintero; Juan Montoro; Juan C Hernández-Boluda; Carlos Carretero; Aitana Balaguer-Roselló; Manuel Guerreiro; Ignacio Lorenzo; Cristóbal Aguilar; Estela Giménez; David Navarro; Miguel A Sanz; Jaime Sanz; Carlos Solano
Journal:  EJHaem       Date:  2021-03-18

6.  Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients.

Authors:  David Navarro; Paula Amat; Rafael de la Cámara; Javier López; Lourdes Vázquez; David Serrano; José Nieto; Monserrat Rovira; José Luis Piñana; Estela Giménez; Carlos Solano
Journal:  Open Forum Infect Dis       Date:  2016-05-18       Impact factor: 3.835

Review 7.  CMV in Hematopoietic Stem Cell Transplantation.

Authors:  Rafael de la Cámara
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-06-20       Impact factor: 2.576

8.  Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia.

Authors:  José Luis Piñana; Estela Giménez; María Dolores Gómez; Ariadna Pérez; Eva María González; Víctor Vinuesa; Juan Carlos Hernández-Boluda; Juan Montoro; Miguel Salavert; Mar Tormo; Paula Amat; Paula Moles; Carlos Carretero; Aitana Balaguer-Roselló; Jaime Sanz; Guillermo Sanz; Carlos Solano; David Navarro
Journal:  J Infect       Date:  2019-02-21       Impact factor: 6.072

9.  Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.

Authors:  José Luis Piñana; María Dolores Gómez; Ariadna Pérez; Silvia Madrid; Aitana Balaguer-Roselló; Estela Giménez; Juan Montoro; Eva María González; Víctor Vinuesa; Paula Moles; Juan Carlos Hernández-Boluda; Miguel Salavert; Marisa Calabuig; Guillermo Sanz; Carlos Solano; Jaime Sanz; David Navarro
Journal:  Transpl Infect Dis       Date:  2018-06-22       Impact factor: 2.228
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.